A Multicenter Assessment of the Outcomes and Toxicities of Foscarnet for Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex in Immunocompromised Patients.
Sarah P HammondManickam RangarajuMelanie SumnerBurkhard TimmlerPranatharthi H ChandrasekarRobin K AveryPublished in: Open forum infectious diseases (2024)
Among 31 episodes of HSV treated with foscarnet, only half resolved with treatment, and adverse events were common.